OncoMenopause Consortium and HERmedicine
The OncoMenopause Consortium is a specific education initiative of HERmedicine, created to address the critical and often overlooked intersection of menopause and cancer survivorship. Although the Consortium operates with its own Board and dedicated programming for clinicians and consumers, it exists within the same 501(c)(3) nonprofit structure as HERmedicine.
The Consortium’s mission is to advance evidence-based education, foster multidisciplinary collaboration, and improve care delivery for individuals navigating menopause after cancer. By bringing together experts across oncology, internal medicine, gynecology, endocrinology, nursing, psychology, pharmacy, and sexual health, the Consortium works to close persistent gaps in knowledge and practice.
HERmedicine, founded by women’s health expert Lisa Larkin, MD, FACP, MSCP, IF, provides the broader platform that supports this work. As the parent 501(c)(3), HERmedicine advances women’s health more broadly through unbiased, expert-led education and accessible resources.
Together, HERmedicine and the OncoMenopause Consortium form a coordinated, mission-driven ecosystem—one that strengthens evidence-based care, supports clinicians, and empowers survivors with trustworthy information.
Join the Movement
Join a multidisciplinary community of clinicians dedicated to improving outcomes and elevating care after cancer.
Founding Member: $50 for the first 200 members. After the first 200, annual membership is $125.
Join the Community
Become part of a supportive, growing community of survivors committed to learning, connecting, and thriving together after cancer.
survivHERs is entirely free to join.
Together, we’re building a space where knowledge, community, and confidence come together—so no one has to navigate survivorship alone.